300142.SZ
沃森生物
SZSE · Healthcare · C 制造业 · CN
CNY 14.90
−7.45%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
324.5x
EV/EBITDA
36.5x
Market Cap
CNY 23.83B
MomentumView details →
1D Return
−7.45%
YTD Return
+18.97%
RSI (14)
45.0
ValuationView details →
P/E (Fwd)
324.5x
EV/EBITDA
36.5x
Market Cap
CNY 23.83B
RSI (14)
45.0
MomentumView details →
1D Return
−7.45%
YTD Return
+18.97%
Similar companies
Latest newsMore news →
Walvax Biotechnology announced its first-half 2026 results: net profit attributable to shareholders was 54.1922 million yuan, up 25.56% year-on-year.7d agoWalvax Biotechnology announced that its 2026 private placement of shares to specific targets has been accepted for review by the Shenzhen Stock Exchange.8d ago